Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Marianne Månsson
Observed names:
M Månsson,
M. Mansson,
M. Månsson,
Månsson, Marianne
Institution:
University of Gothenburg
Observed institutions:
Sahlgrenska University Hospital,
Karolinska Institutet,
AstraZeneca (Sweden),
University of Tampere,
University of Gothenburg
ORCID:
0000-0002-1460-4062
Observed ORCIDs:
0000-0002-1460-4062,
0000-0001-5808-1809
OpenAlex ID:
A5066906201
A 16-yr Follow-up of the European Randomized study of Screening for Prostate Cancer
2019
·
Jonas Hugosson
, Monique J. Roobol
, et al.
·
European Urology
·
754
Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only
2022
·
Jonas Hugosson
, Marianne Månsson
, et al.
·
New England Journal of Medicine
·
416
PDF
Results after Four Years of Screening for Prostate Cancer with PSA and MRI
2024
·
Jonas Hugosson
, Rebecka Arnsrud Godtman
, et al.
·
New England Journal of Medicine
·
140
European Study of Prostate Cancer Screening — 23-Year Follow-up
2025
·
Monique J. Roobol
, Ivo I. de Vos
, et al.
·
New England Journal of Medicine
·
129
The Association Between Age, Prostate Cancer Risk, and Higher Gleason Score in a Long-term Screening Program: Results from the Göteborg-1 Prostate Cancer Screening Trial
2022
·
Rebecka Arnsrud Godtman
, Karin Stinesen Kollberg
, et al.
·
European Urology
·
81
PDF
Impaired adipose tissue lipid storage, but not altered lipolysis, contributes to elevated levels of NEFA in type 2 diabetes. Degree of hyperglycemia and adiposity are important factors
2016
·
Maria J Pereira
, Stanko Skrtic
, et al.
·
Metabolism
·
66
The GÖTEBORG prostate cancer screening 2 trial: a prospective, randomised, population-based prostate cancer screening trial with prostate-specific antigen testing followed by magnetic resonance imaging of the prostate
2021
·
Kimia Kohestani
, Marianne Månsson
, et al.
·
Scandinavian Journal of Urology
·
61
PDF
Bi- or multiparametric MRI in a sequential screening program for prostate cancer with PSA followed by MRI? Results from the Göteborg prostate cancer screening 2 trial
2021
·
Jonas Wallström
, Kjell Geterud
, et al.
·
European Radiology
·
51
PDF
Performance and inter-observer variability of prostate MRI (PI-RADS version 2) outside high-volume centres
2019
·
Kimia Kohestani
, Jonas Wallström
, et al.
·
Scandinavian Journal of Urology
·
47
Prostate Cancers in the Prostate-specific Antigen Interval of 1.8–3 ng/ml: Results from the Göteborg-2 Prostate Cancer Screening Trial
2024
·
Fredrik Möller
, Marianne Månsson
, et al.
·
European Urology
·
42
Young Age on Starting Prostate-specific Antigen Testing Is Associated with a Greater Reduction in Prostate Cancer Mortality: 24-Year Follow-up of the Göteborg Randomized Population-based Prostate Cancer Screening Trial
2022
·
Sigrid V. Carlsson
, Rebecka Arnsrud Godtman
, et al.
·
European Urology
·
42
PDF
Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial
2024
·
Andreas Josefsson
, Marianne Månsson
, et al.
·
European Urology
·
40
Circulating tumor cells mirror bone metastatic phenotype in prostate cancer
2018
·
Andreas Josefsson
, Karin Larsson
, et al.
·
Oncotarget
·
32
PDF
Prostate Cancer Screening with Magnetic Resonance Imaging: Results from the Second Round of the Göteborg Prostate Cancer Screening 2 Trial
2021
·
Jonas Wallström
, Kjell Geterud
, et al.
·
European Urology Oncology
·
31
PDF
Effects of a novel potent melanin‐concentrating hormone receptor 1 antagonist, AZD1979, on body weight homeostasis in mice and dogs
2016
·
Karolina Ploj
, Lambertus Benthem
, et al.
·
British Journal of Pharmacology
·
29
PDF
Active Surveillance for Screen-detected Low- and Intermediate-risk Prostate Cancer: Extended Follow-up up to 25 Years in the GÖTEBORG-1 Trial
2025
·
Emmeli Palmstedt
, Marianne Månsson
, et al.
·
European Urology
·
23
The value of a bladder-filling protocol for patients with prostate cancer who receive post-operative radiation: results from a prospective clinical trial
2019
·
Karin Braide
, Jon Kindblom
, et al.
·
Acta Oncologica
·
23
PDF
Could Differences in Treatment Between Trial Arms Explain the Reduction in Prostate Cancer Mortality in the European Randomized Study of Screening for Prostate Cancer?
2019
·
Sigrid V. Carlsson
, Marianne Månsson
, et al.
·
European Urology
·
20
Prostate cancer risk assessment in men with an initial P.S.A. below 3 ng/mL: results from the Göteborg randomized population-based prostate cancer screening trial
2018
·
Maria Frånlund
, Rebecka Arnsrud Godtman
, et al.
·
Scandinavian Journal of Urology
·
19
Long-term Outcomes for Men in a Prostate Screening Trial with an Initial Benign Prostate Biopsy: A Population-based Cohort
2019
·
Emmeli Palmstedt
, Marianne Månsson
, et al.
·
European Urology Oncology
·
15
Patient- and Procedure-specific Risk Factors for Urinary Incontinence After Robot-assisted Radical Prostatectomy: A Nationwide, Population-based Study
2025
·
Katarina Koss Modig
, Rebecka Arnsrud Godtman
, et al.
·
European Urology Oncology
·
12
Predictors for complication in renal cancer surgery: a national register study
2023
·
John Åkerlund
, Pernilla Sundqvist
, et al.
·
Scandinavian Journal of Urology
·
11
PDF
Biochemical recurrence after radical prostatectomy – a large, comprehensive, population-based study with long follow-up
2022
·
Elin Axén
, Johan Stranne
, et al.
·
Scandinavian Journal of Urology
·
11
Degree of Preservation of Neurovascular Bundles in Radical Prostatectomy and Recurrence of Prostate Cancer
2021
·
Elin Axén
, Rebecka Arnsrud Godtman
, et al.
·
European Urology Open Science
·
10
PDF
A comparison of side-effects and quality-of-life in patients operated on for prostate cancer with and without salvage radiation therapy
2020
·
Karin Braide
, Jon Kindblom
, et al.
·
Scandinavian Journal of Urology
·
8
Show more works
View as search
Works count:
49
Citation count:
2,162
H-index:
19
I10-index:
24
Year
Topic
Type